HALEON PLC-ADR (HLN) Stock Price, Quote, News and Overview
NYSE:HLN - New York Stock Exchange, Inc. - US4055521003 - ADR - Currency: USD
HLN Quote, Performance and Key Statistics
10.22
+0.06 (+0.59%)
The current stock price of HLN is 10.22 USD. In the past month the price decreased by -1.64%. In the past year, price increased by 24.33%.
HLN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
| JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
| MRK | MERCK & CO. INC. | 10.21 | 196.28B | ||
| PFE | PFIZER INC | 7.12 | 125.57B | ||
| SNY | SANOFI-ADR | 11.41 | 124.61B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
| GSK | GSK PLC-SPON ADR | 8.32 | 72.88B | ||
| ZTS | ZOETIS INC | 25.11 | 66.32B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.47B |
Related stock screener links
About HLN
Company Profile
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey. The company went IPO on 2022-07-18. The firm's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Company Info
HALEON PLC-ADR
Building 5, First Floor, The Heights
Weybridge SURREY GB
Employees: 25408
Company Website: https://www.haleon.com/
Investor Relations: https://www.haleon.com/investors
Phone: 441932822000
HALEON PLC-ADR / HLN FAQ
What is the stock price of HALEON PLC-ADR today?
The current stock price of HLN is 10.22 USD. The price increased by 0.59% in the last trading session.
What is the ticker symbol for HALEON PLC-ADR stock?
The exchange symbol of HALEON PLC-ADR is HLN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is HLN stock listed?
HLN stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for HALEON PLC-ADR stock?
25 analysts have analysed HLN and the average price target is 11.13 USD. This implies a price increase of 8.95% is expected in the next year compared to the current price of 10.22. Check the HALEON PLC-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HALEON PLC-ADR worth?
HALEON PLC-ADR (HLN) has a market capitalization of 46.14B USD. This makes HLN a Large Cap stock.
How many employees does HALEON PLC-ADR have?
HALEON PLC-ADR (HLN) currently has 25408 employees.
What are the support and resistance levels for HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a support level at 10.08 and a resistance level at 10.39. Check the full technical report for a detailed analysis of HLN support and resistance levels.
Is HALEON PLC-ADR (HLN) expected to grow?
The Revenue of HALEON PLC-ADR (HLN) is expected to grow by 2.71% in the next year. Check the estimates tab for more information on the HLN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HALEON PLC-ADR (HLN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HLN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HLN, evaluating the profitability, health, valuation and growth aspects
- HALEON PLC-ADR (HLN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HALEON PLC-ADR (HLN) Sales and EPS estimates to see what analysts future expectations are.
- HALEON PLC-ADR (HLN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HALEON PLC-ADR (HLN) Insider and Institutional Ownership to learn about the owners and their transactions.
- HALEON PLC-ADR (HLN) Stock Chart to make your own analysis
- HALEON PLC-ADR (HLN) Latest news and press-releases to stay up to date.
Does HALEON PLC-ADR (HLN) stock pay dividends?
HALEON PLC-ADR (HLN) has a dividend yield of 1.81%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of HLN dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of HALEON PLC-ADR (HLN)?
The PE ratio for HALEON PLC-ADR (HLN) is 21.29. This is based on the reported non-GAAP earnings per share of 0.48 and the current share price of 10.22 USD. Check the full fundamental report for a full analysis of the valuation metrics for HLN.
What is the Short Interest ratio of HALEON PLC-ADR (HLN) stock?
The outstanding short interest for HALEON PLC-ADR (HLN) is 0.64% of its float. Check the ownership tab for more information on the HLN short interest.
HLN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HLN. When comparing the yearly performance of all stocks, HLN is one of the better performing stocks in the market, outperforming 90.67% of all stocks.
HLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to HLN. HLN has an excellent profitability rating, but there are some minor concerns on its financial health.
HLN Financial Highlights
Over the last trailing twelve months HLN reported a non-GAAP Earnings per Share(EPS) of 0.48. The EPS increased by 6.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.84% | ||
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.53 |
HLN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to HLN. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 9.53% and a revenue growth 2.71% for HLN